Insider Trading activities at Zevra Therapeutics, Inc. (ZVRA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zevra Therapeutics, Inc. (ZVRA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zevra Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1434647.

Total stock buying since 2015: $9,708,454.
Total stock sales since 2015: $1,140,997.
Total stock option exercises since 2015: $77,496.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Zevra Therapeutics, Inc.* (*ZVRA*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2025	15,300	$127,795	140,317	$1,140,997	390,331	$0
2024	22,000	$140,270	0	$0	0	$0
2023	77,819	$370,469	0	$0	0	$0
2022	27,400	$127,990	0	$0	0	$0
2021	14,290	$130,013	0	$0	0	$0
2020	192,000	$51,657	0	$0	0	$0
2019	105,250	$70,864	0	$0	0	$0
2018	2,325,358	$7,303,742	0	$0	3,333	$15,498
2017	361,963	$1,194,243	0	$0	0	$0
2016	25,000	$114,411	0	$0	13,333	$61,998
2015	7,000	$77,000	0	$0	0	$0

Table 2. Monthly summary of insider trading at *Zevra Therapeutics, Inc.* (*ZVRA*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2025-08	5,000	$45,824	0	$0	0	$0
2025-06	0	$0	24,000	$221,016	66,666	$0
2025-03	10,300	$81,971	0	$0	0	$0
2025-02	0	$0	116,317	$919,981	0	$0
2025-01	0	$0	0	$0	323,665	$0
2024-07	22,000	$140,270	0	$0	0	$0
2023-09	21,500	$107,613	0	$0	0	$0
2023-06	600	$3,428	0	$0	0	$0
2023-05	14,140	$71,430	0	$0	0	$0
2023-03	31,444	$132,697	0	$0	0	$0
2023-01	10,135	$55,301	0	$0	0	$0
2022-09	1,000	$5,982	0	$0	0	$0
2022-05	26,400	$122,008	0	$0	0	$0
2021-11	6,260	$50,143	0	$0	0	$0
2021-09	1,380	$12,138	0	$0	0	$0
2021-08	5,000	$44,610	0	$0	0	$0
2021-06	1,500	$21,645	0	$0	0	$0
2021-05	150	$1,477	0	$0	0	$0
2020-08	23,000	$15,119	0	$0	0	$0
2020-06	111,500	$21,078	0	$0	0	$0
2020-05	11,500	$2,104	0	$0	0	$0
2020-03	46,000	$13,356	0	$0	0	$0
2019-12	32,250	$12,888	0	$0	0	$0
2019-09	73,000	$57,976	0	$0	0	$0

Table 3. Detailed insider trading at *Zevra Therapeutics, Inc.* (*ZVRA*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2025-08-19	Bode John B (Director)	Buy	5,000	9.16	45,824
2025-06-26	Thompson Rahsaan (Chief Legal & Compliance)	Sale	24,000	9.21	221,016
2025-06-21	Thompson Rahsaan (Chief Legal & Compliance)	Option Ex	66,666	.00	0
2025-03-28	Watton Corey Michael (Director)	Buy	300	7.84	2,351
2025-03-19	Bode John B (Director)	Buy	10,000	7.96	79,620
2025-02-14	Mcfarlane Neil F. (President and CEO)	Sale	30,544	8.05	245,970
2025-02-13	Schafer Joshua (CCO & EVP, Bus. Development)	Sale	10,500	7.86	82,530
2025-02-13	Sangiovanni Timothy J. (SVP, Finance & Corp Controller)	Sale	3,000	7.86	23,589
2025-02-13	Mcfarlane Neil F. (President and CEO)	Sale	61,273	7.86	481,421
2025-02-13	Clifton R. Laduane (CFO & Treasurer)	Sale	11,000	7.86	86,471
2025-01-31	Schafer Joshua (CCO & EVP, Bus. Development)	Option Ex	35,333	.00	0
2025-01-31	Sangiovanni Timothy J. (SVP, Finance & Corp Controller)	Option Ex	11,666	.00	0
2025-01-31	Mcfarlane Neil F. (President and CEO)	Option Ex	233,333	.00	0
2025-01-31	Clifton R. Laduane (CFO & Treasurer)	Option Ex	43,333	.00	0
2024-07-17	Clifton R. Laduane (CFO & Treasurer)	Buy	2,000	6.77	13,540
2024-07-16	Anderson Thomas (Director)	Buy	10,000	6.81	68,070
2024-07-12	Bode John B (Director)	Buy	10,000	5.87	58,660
2023-09-06	Anderson Thomas (Director)	Buy	10,000	4.88	48,760
2023-09-06	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	1,000	4.96	4,959
2023-09-05	Schafer Joshua (CCO & EVP, Bus. Development)	Buy	500	5.13	2,564
2023-09-05	Bode John B (Director)	Buy	10,000	5.13	51,330
2023-06-23	Watton Corey Michael (Director)	Buy	275	5.95	1,635
2023-06-09	Watton Corey Michael (Director)	Buy	325	5.52	1,793
2023-05-30	Watton Corey Michael (Director)	Buy	400	5.11	2,042
2023-05-19	Schafer Joshua (CCO & EVP, Bus. Development)	Buy	1,000	5.42	5,416
2023-05-18	Bode John B (Director)	Buy	10,000	5.04	50,420
2023-05-18	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	2,740	4.95	13,552
2023-03-17	Seymour Tamara A (Director)	Buy	519	4.82	2,502
2023-03-14	Schafer Joshua (CCO & EVP, Bus. Development)	Buy	2,000	4.61	9,218
2023-03-10	Sangiovanni Timothy J. (SVP, Corporate Controller)	Buy	1,200	4.14	4,964
2023-03-10	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	1,725	4.15	7,158
2023-03-09	Plooster Matthew R (Director)	Buy	11,000	4.20	46,145
2023-03-09	Pascoe Richard W (Chief Executive Officer)	Buy	10,000	4.20	41,980
2023-03-09	Tierney David S (Director)	Buy	5,000	4.15	20,730
2023-01-13	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	635	5.70	3,621
2023-01-13	Pascoe Richard W (Chief Executive Officer)	Buy	9,500	5.44	51,680
2022-09-30	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	1,000	5.98	5,982
2022-05-25	Mickle Travis C (President & CEO)	Buy	13,000	4.38	56,901
2022-05-25	Tierney David S (Director)	Buy	2,000	4.39	8,780
2022-05-20	Seymour Tamara A (Director)	Buy	200	4.87	974
2022-05-18	Plooster Matthew R (Director)	Buy	5,000	4.96	24,775
2022-05-18	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	1,200	5.00	5,998
2022-05-18	Pascoe Richard W (Executive Chairman)	Buy	5,000	4.92	24,580
2021-11-30	Pascoe Richard W (Executive Chairman)	Buy	1,500	7.88	11,821
2021-11-30	Tierney David S (Director)	Buy	2,000	7.79	15,578
2021-11-18	Mickle Travis C (President & CEO)	Buy	2,250	8.23	18,517
2021-11-18	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	510	8.29	4,227
2021-09-29	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	215	9.38	2,016
2021-09-20	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	935	8.59	8,028
2021-09-01	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	230	9.11	2,094
2021-08-30	Mickle Travis C (President & CEO)	Buy	5,000	8.92	44,610
2021-06-14	Mickle Travis C (President & CEO)	Buy	1,500	14.43	21,645
2021-05-27	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	150	9.85	1,477
2020-08-26	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	1,000	.84	839
2020-08-18	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	2,000	.69	1,390
2020-08-18	Pascoe Richard W (Director)	Buy	10,000	.64	6,360
2020-08-18	Tierney David S (Director)	Buy	10,000	.65	6,530
2020-06-11	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	1,500	.19	288
2020-06-02	Mickle Travis C (President & CEO)	Buy	110,000	.19	20,790
2020-05-26	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	11,500	.18	2,104
2020-03-25	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	1,000	.22	218
2020-03-13	Sangiovanni Timothy J. (VP, Corporate Controller)	Buy	4,000	.20	800
2020-03-11	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	8,000	.25	2,008
2020-03-10	Sangiovanni Timothy J. (VP, Corporate Controller)	Buy	7,667	.25	1,947
2020-03-09	Sangiovanni Timothy J. (VP, Corporate Controller)	Buy	333	.25	83
2020-03-05	Mickle Travis C (President & CEO)	Buy	25,000	.33	8,300
2019-12-31	Johnson Gordon K (Chief Business Officer)	Buy	20,000	.39	7,780
2019-12-27	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	12,250	.42	5,108
2019-09-25	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	3,650	.74	2,719
2019-09-24	Sangiovanni Timothy J. (VP, Corporate Controller)	Buy	3,000	.74	2,220
2019-09-24	Mickle Travis C (President & CEO)	Buy	50,000	.79	39,400
2019-09-16	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	5,000	.87	4,365
2019-09-11	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	500	.94	472
2019-09-09	Johnson Gordon K (Chief Business Officer)	Buy	10,000	.81	8,149
2019-09-06	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	850	.77	651
2018-10-12	Sangiovanni Timothy J. (VP, Corporate Controller)	Buy	1,500	2.50	3,750
2018-10-12	Johnson Gordon K (Chief Business Officer)	Buy	1,000	2.61	2,610
2018-10-12	Mickle Travis C (President & CEO)	Buy	5,000	2.55	12,765
2018-10-11	Sangiovanni Timothy J. (VP, Corporate Controller)	Buy	1,500	2.55	3,824
2018-10-11	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	650	2.54	1,651
2018-10-10	Johnson Gordon K (Chief Business Officer)	Buy	3,000	2.62	7,869
2018-10-05	Bluhm Andrew G (10% Owner)	Buy	2,000,000	3.00	6,000,000
2018-07-30	Bluhm Andrew G (10% Owner)	Buy	304,283	4.00	1,217,132
2018-05-31	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	525	6.10	3,202
2018-05-15	Cohen Daniel L (EVP, Govt. & Public Relations)	Buy	7,900	6.45	50,939
2018-03-23	Thompson Danny L (Director)	Option Ex	3,333	4.65	15,498
2017-11-27	Cohen Daniel L (EVP, Govt. & Public Relations)	Buy	7,500	3.77	28,312
2017-09-25	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	300	3.77	1,132
2017-09-14	Bluhm Andrew G (10% Owner)	Buy	138,857	3.30	458,644
2017-09-13	Bluhm Andrew G (10% Owner)	Buy	187,031	3.25	608,037
2017-08-24	Cohen Daniel L (EVP, Govt. & Public Relations)	Buy	5,000	2.58	12,880
2017-08-24	Johnson Gordon K (Chief Business Officer)	Buy	4,000	2.60	10,388
2017-06-20	Mickle Travis C (President & CEO)	Buy	8,000	3.45	27,592
2017-06-19	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	275	3.30	907
2017-05-25	Cohen Daniel L (EVP, Govt. & Public Relations)	Buy	2,500	4.12	10,305
2017-03-31	Cohen Daniel L (EVP, Govt. & Public Relations)	Buy	1,000	4.70	4,700
2017-03-29	Cohen Daniel L (EVP, Govt. & Public Relations)	Buy	1,500	4.33	6,502
2017-03-24	Clifton R. Laduane (CFO, Secretary & Treasurer)	Buy	1,000	4.24	4,244
2017-03-22	Mickle Christal M M (VP, Operations & Product Dvlp.)	Buy	2,000	4.10	8,200
2017-03-22	Mickle Travis C (President & CEO)	Buy	2,000	4.10	8,200
2017-03-20	Tierney David S (Director)	Buy	1,000	4.20	4,200
2016-11-30	Cohen Daniel L (EVP, Govt and Public Relations)	Buy	5,000	3.49	17,440
2016-09-06	Cohen Daniel L (EVP, Govt and Public Relations)	Buy	3,690	5.01	18,490
2016-09-02	Cohen Daniel L (EVP, Govt and Public Relations)	Buy	6,310	4.59	28,981
2016-08-17	Mickle Christal M M (VP Prod Dev)	Buy	5,000	4.95	24,750
2016-08-17	Mickle Travis C (President & CEO)	Buy	5,000	4.95	24,750
2016-04-04	Thompson Danny L (Director)	Option Ex	13,333	4.65	61,998
2015-04-21	Johnson Gordon K (COO & CFO)	Buy	2,000	11.00	22,000
2015-04-21	Tierney David S (Director)	Buy	5,000	11.00	55,000

Insider trading activities including stock purchases, stock sales, and option exercises of ZVRA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zevra Therapeutics, Inc. (symbol ZVRA, CIK number 1434647) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month